Results 261 to 270 of about 13,243 (286)

High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.

Clinical Laboratory, 2012
D. Weiss, E. Strasser, J. Ringwald, R. Zimmermann, R. Eckstein   +4 more
semanticscholar   +1 more source

Heparin and Ristocetin-lnduced Platelet Aggregation

Thrombosis and Haemostasis, 1976
Yüksel Pekçelen, Seref Inceman
openaire   +3 more sources

Evaluation of an automated platelet‐based assay of ristocetin cofactor activity

Haemophilia, 2011
Anthony Lawrie, Ian J. Mackie, Samuel J. Machin, Flora Peyvandi   +3 more
semanticscholar   +1 more source

Redeeming ristocetin

Blood, 2010
openaire   +2 more sources

Ristocetin-induced self-aggregation of von Willebrand factor

European Biophysics Journal, 2010
M. Papi, G. Maulucci, M. De Spirito, M. Missori, G. Arcòvito, S. Lancellotti, E. di Stasio, R. De Cristofaro, A. Arcovito   +8 more
semanticscholar   +1 more source

Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children

Thrombosis and Haemostasis, 2010
J. Frontroth, M. Hepner, G. Sciuccati, A. F. Torres, G. Pieroni, M. Bonduel   +5 more
semanticscholar   +1 more source

Proteolytic activity in ristocetin preparations

Thrombosis Research, 1974
F.J. Morgan, Anna Goh, B G Firkin
openaire   +2 more sources

Ristocetin - A New Tool in the Investigation of Platelet Aggregation

Thrombosis and Haemostasis, 1971
M. Howard, B. Firkin
semanticscholar   +1 more source

Ristocetin

1967
openaire   +1 more source

COMPLICATIONS OF RISTOCETIN THERAPY

The Lancet, 1958
openaire   +2 more sources